We are live on
!
Find out more
RI
RTW Investments Portfolio holdings
AUM
$10B
1-Year Est. Return
135.35%
This Fund
S&P 500
This Quarter
Est. Return
+13.47%
1 Year Est. Return
+135.35%
3 Year Est. Return
+383.62%
5 Year Est. Return
+523.94%
10 Year Est. Return
+15,981.64%
AUM
$10B
AUM Growth
+$66.4M
(+0.67%)
Cap. Flow
+$419M
Cap. Flow
% of AUM
4.17%
Top 10 Holdings %
Top 10 Hldgs %
49.99%
Holding
98
New
7
Increased
30
Reduced
13
Closed
10
Top Buys
| 1 |
CG Oncology
CGON
|
+$282M |
| 2 |
Celcuity
CELC
|
+$271M |
| 3 |
Erasca
ERAS
|
+$189M |
| 4 |
Tango Therapeutics
TNGX
|
+$164M |
| 5 |
iRhythm Holdings
IRTC
|
+$70.2M |
Top Sells
| 1 |
Penumbra
PEN
|
+$269M |
| 2 |
Axsome Therapeutics
AXSM
|
+$162M |
| 3 |
Insulet
PODD
|
+$92.3M |
| 4 |
MASI
Masimo
MASI
|
+$88.9M |
| 5 |
APLS
Apellis Pharmaceuticals
APLS
|
+$85.8M |
Sector Composition
| 1 | Healthcare | 99.92% |
| 2 | Financials | 0.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
AtaiBeckley Inc
ATAI
$2.63B
| $7.08M | 0.07% |
2,000,000
| – | – |
|
|
CBIO
77
Crescent Biopharma
CBIO
$456M
| $6.85M | 0.07% |
372,856
| – | – |
|
78
Larimar Therapeutics
LRMR
$383M
| $6.75M | 0.07% |
1,500,000
-1,625,000
| -52% | -$6.5M |
|
79
Tenax Therapeutics
TENX
$401M
| $5.92M | 0.06% |
370,246
-8,100
| -2% | -$110K |
|
|
DFTX
80
Definium Therapeutics
DFTX
$6.14B
| $5.67M | 0.06% |
300,000
| – | – |
|
|
LMRI
81
Lumexa Imaging Holdings
LMRI
$1.09B
| $5.59M | 0.06% |
650,000
| – | – |
|
82
4D Molecular Therapeutics
FDMT
$588M
| $4.43M | 0.04% |
475,737
| – | – |
|
|
MDLN
83
Medline Inc
MDLN
$34.5B
| $3.12M | 0.03% |
70,000
| – | – |
|
|
OMDA
84
Omada Health Inc
OMDA
$1.45B
| $2.51M | 0.03% |
200,000
| – | – |
|
85
Disc Medicine
IRON
$2.84B
| $1.92M | 0.02% |
30,000
| – | – |
|
|
IMA
86
ImageneBio Inc
IMA
$65M
| $1.67M | 0.02% |
334,445
| – | – |
|
87
Exagen
XGN
$103M
| $1.19M | 0.01% |
395,231
-395,231
| -50% | -$1.53M |
|
88
Rocket Pharmaceuticals Warrant
RCKTW
$310K
| $7.21K | ﹤0.01% |
350,000
| – | – |
|
|
ALUR
89
DELISTED
Allurion Technologies
ALUR
| – | – |
-5,891,430
| Closed | -$7.25M |
|
|
90
Axsome Therapeutics
AXSM
$12.3B
| – | – |
-888,001
| Closed | -$162M |
|
91
Corvus Pharmaceuticals
CRVS
$1.2B
| – | – |
-447,607
| Closed | -$3.45M |
|
92
Structure Therapeutics
GPCR
$3.39B
| – | – |
-100,000
| Closed | -$6.96M |
|
93
IQVIA
IQV
$35.3B
| – | – |
-46,000
| Closed | -$10.4M |
|
|
MASI
94
DELISTED
Masimo
MASI
| – | – |
-683,294
| Closed | -$88.9M |
|
|
95
Penumbra
PEN
$12.6B
| – | – |
-866,499
| Closed | -$269M |
|
|
96
Insulet
PODD
$11.6B
| – | – |
-324,600
| Closed | -$92.3M |
|
|
RAPT
97
DELISTED
RAPT Therapeutics
RAPT
| – | – |
-1,637,165
| Closed | -$55.5M |
|
|
TEM
98
Tempus AI
TEM
$10.1B
| – | – |
-200,000
| Closed | -$11.8M |
|
Similar funds
BEI
ECM
BHCM
MG
LWCFA
HRCM
RA
VNIM